Boilerplate
FinallyMe is the GLP-1 companion app that turns medications like Ozempic®, Wegovy®, Zepbound®, Mounjaro®, and compounded semaglutide or tirzepatide from an expensive guess into a protocol users command: injection-site rotation with the next site called automatically, dose tracking with an estimated medication-level curve, protein-first macros, a timestamped side-effect map, and weight trends instead of scale noise. FinallyMe is private by design. Health data lives on-device by default, is never sold, and cloud/AI features are strictly opt-in. FinallyMe is a wellness tracker, not a medical service, made by The Good Habits Company LLC, an independent studio in Indiana. finallyme.app
Fast facts
| Fact | Detail |
|---|---|
| Product | FinallyMe. GLP-1 companion app (iOS & Android, launching 2026) |
| Maker | The Good Habits Company LLC, Indiana, USA. Independent and self-funded |
| Pricing | Founding lifetime seats pre-launch, tiered $29 → $49 → $69 as 1,250 seats fill; $11.99/mo or $71.99/yr after launch |
| Privacy model | On-device by default; cloud sync and online AI strictly opt-in; no ads; data never sold |
| Trackers | Doses & a pharmacokinetic level curve, body-map injection rotation, a 31,000-food catalog with barcode & AI photo logging, side-effect radar, weight/body fat/progress photos, workouts with muscle recovery, hydration, habits, a unified daily timeline, and an insights Coach |
| Signature | Two switchable visual experiences, Friendly (Apple Health-style) and Professional (Apple Fitness-style), running the same features |
| Affiliations | None. Not affiliated with Novo Nordisk, Eli Lilly, or any pharmacy or telehealth prescriber |
Assets & interviews
Logo pack, app screenshots, and founder photos available on request. We typically reply same-day: support@thegoodhabits.company.